Turns out enzyme displays lower levels of activity in intellectual disability and that it is possible to inhibit it in breast cancer where it is overactive. The study conducted at the University of Copenhagen suggests that enzyme may be a target for potential therapies. In recent years enzyme has been linked to various diseases. Researchers have discovered that the gene coding for the enzyme is overexpressed in patients suffering from ER-positive breast cancer and mutated in intellectual disability but up until now no one has been able to outline the behaviour of the enzyme. Therefore researchers from the University of Copenhagen
